CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

amoxicillin and clavulanate potassium

· ingredient clavulanatePenicillins with extended spectrum· AMOXICILLIN 250 mg/5mL; CLAVULANATE POTASSIUM 62.5 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.43099
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other clavulanate products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
Amoxicillin and Clavulanate Potassium$0.06030−$0.37070
AUGMENTIN ES-600$0.06299−$0.36800
Amoxicillin and Clavulanate Potassium$0.28188−$0.14910
amoxicillin and clavulanate potassium$0.28188−$0.14910
Augmentin$0.43099+$0.00000
amoxicillin and clavulanate potassium$6.09+$5.66

Medicare Part D coverage · CY2026

On 320 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.